Amare Firehiwot, Gashaw Tigist, Sisay Mekonnen, Baye Yohannes, Tesfa Tewodros
Clinical Pharmacy Unit, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Pharmacology and Toxicology Unit, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
SAGE Open Med. 2021 Oct 20;9:20503121211051525. doi: 10.1177/20503121211051525. eCollection 2021.
Drug use evaluation is a method of obtaining information to identify problems related to drug use and if properly developed, a means of correcting the problems. Ceftriaxone is among the most commonly utilized cephalosporins. Owing to a broad spectrum of activity and being used empirically, ceftriaxone has been used inappropriately posing a risk for development of antimicrobial resistance. This study is, therefore, designed to evaluate the appropriateness of ceftriaxone utilization in government hospitals in Harar town.
A retrospective cross-sectional study was conducted in four government hospitals of Harar town by reviewing the medical records of 271 patients who received ceftriaxone from 1 January to 31 December 2016. Systematic random sampling was utilized to capture the medical records. Data were entered and analyzed using SPSS version 22.
From the 271 medical records reviewed majority of patients were from surgical ward ( = 85, 31.4%) followed by gynecology and obstetrics ward ( = 67, 24.7%). Demographically, the majority of the patients were female ( = 142, 52.4%). Patients in the age group of 20-29 years were dominant ( = 98, 36.2%). A total of 71 drugs were co-administered with ceftriaxone, the most common being metronidazole followed by tramadol. Among the co-administered drugs, unfractionated heparin ( = 6), warfarin ( = 5), and enoxaparin ( = 1) were found to have a moderate drug interaction with ceftriaxone. Ceftriaxone was commonly used for post-operative prophylaxis ( = 80, 27.5%) followed by for the management of pneumonia ( = 62, 21.3%). The result of ceftriaxone use evaluation showed that majority ( = 190, 70.1%) were found to be inappropriate. The inappropriate utilization was primarily due to wrong indication (indications for which ceftriaxone was not the primary option) ( = 114, 60.0%) followed by wrong duration ( = 54, 28.4%).
Ceftriaxone was used inappropriately in more than two-thirds of the patients, with wrong indication and wrong duration contributing the majority. Inappropriate use of antibiotics may potentially lead to the emergence and spread of drug-resistant microorganisms and also ultimately exposes the patient to treatment failure, prolonged hospital stay, and higher cost of therapy.
药物使用评估是一种获取信息以识别与药物使用相关问题的方法,如果方法得当,也是纠正这些问题的一种手段。头孢曲松是最常用的头孢菌素之一。由于其抗菌谱广且常被经验性使用,头孢曲松一直存在使用不当的情况,这增加了产生耐药性的风险。因此,本研究旨在评估哈拉尔镇政府医院头孢曲松的使用合理性。
通过回顾2016年1月1日至12月31日期间接受头孢曲松治疗的271例患者的病历,在哈拉尔镇的四家政府医院进行了一项回顾性横断面研究。采用系统随机抽样方法获取病历。使用SPSS 22版软件录入和分析数据。
在审查的271份病历中,大多数患者来自外科病房(85例,占31.4%),其次是妇产科病房(67例,占24.7%)。从人口统计学来看,大多数患者为女性(142例,占52.4%)。年龄在20 - 29岁的患者占主导(98例,占36.2%)。共有71种药物与头孢曲松联合使用,最常见的是甲硝唑,其次是曲马多。在联合使用的药物中,普通肝素(6例)、华法林(5例)和依诺肝素(1例)被发现与头孢曲松有中度药物相互作用。头孢曲松常用于术后预防(80例,占27.5%),其次是用于治疗肺炎(62例,占21.3%)。头孢曲松使用评估结果显示,大多数(190例,占70.1%)使用不当。使用不当主要是由于适应证错误(头孢曲松并非首选适应证)(114例,占60.0%),其次是疗程错误(54例,占28.4%)。
超过三分之二的患者头孢曲松使用不当,其中适应证错误和疗程错误占了大多数。抗生素的不当使用可能会导致耐药微生物的出现和传播,最终还会使患者面临治疗失败、住院时间延长和治疗费用增加的风险。